Xvivo Perfusion AB (publ) logo

Xvivo Perfusion AB (publ)

SSE:XVIVO.ST

Overview | Financials
Company Name Xvivo Perfusion AB (publ)
Symbol XVIVO.ST
Currency SEK
Price 282
Market Cap 8,882,859,000
Dividend Yield 0%
52-week-range 205.5 - 343.5
Industry Medical Devices
Sector Healthcare
CEO Mr. Christoffer Rosenblad
Website https://www.xvivoperfusion.com

An error occurred while fetching data.

About Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf

Related Stocks

BioArctic AB (publ) logo

BioArctic AB (publ)

BIOA-B.ST

227.8 SEK

Surgical Science Sweden AB (publ) logo

Surgical Science Sweden AB (publ)

SUS.ST

179.1 SEK

BICO Group AB (publ) logo

BICO Group AB (publ)

BICO.ST

45.4 SEK

CellaVision AB (publ) logo

CellaVision AB (publ)

CEVI.ST

257 SEK

Calliditas Therapeutics AB (publ) logo

Calliditas Therapeutics AB (publ)

CALTX.ST

107.8 SEK

Ambea AB (publ) logo

Ambea AB (publ)

AMBEA.ST

57.2 SEK

Attendo AB (publ) logo

Attendo AB (publ)

ATT.ST

37.8 SEK

BioGaia AB (publ) logo

BioGaia AB (publ)

BIOG-B.ST

124.4 SEK

Bonesupport Holding AB (publ) logo

Bonesupport Holding AB (publ)

BONEX.ST

189.8 SEK

Probi AB (publ) logo

Probi AB (publ)

PROB.ST

203 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD